Karl Walravens

3.0k total citations
54 papers, 2.1k citations indexed

About

Karl Walravens is a scholar working on Epidemiology, Small Animals and Infectious Diseases. According to data from OpenAlex, Karl Walravens has authored 54 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 23 papers in Small Animals and 21 papers in Infectious Diseases. Recurrent topics in Karl Walravens's work include Brucella: diagnosis, epidemiology, treatment (18 papers), Respiratory viral infections research (13 papers) and Influenza Virus Research Studies (12 papers). Karl Walravens is often cited by papers focused on Brucella: diagnosis, epidemiology, treatment (18 papers), Respiratory viral infections research (13 papers) and Influenza Virus Research Studies (12 papers). Karl Walravens collaborates with scholars based in Belgium, France and United Kingdom. Karl Walravens's co-authors include Jacques Godfroid, Jean‐Jacques Letesson, Axel Cloeckaert, Bruno Garin‐Bastuji, David Frétin, Jean‐Pierre Liautard, Stephan Köhler, Claude Saegerman, Anne Tibor and Marc Govaerts and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and Infection and Immunity.

In The Last Decade

Karl Walravens

54 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Walravens Belgium 24 1.3k 1.2k 708 447 431 54 2.1k
David Frétin Belgium 23 1.4k 1.1× 777 0.6× 814 1.1× 300 0.7× 172 0.4× 53 2.0k
Bruno Garin‐Bastuji France 31 2.5k 1.9× 1.4k 1.2× 1.5k 2.1× 260 0.6× 303 0.7× 75 3.0k
Ramesh Vemulapalli United States 26 893 0.7× 678 0.6× 298 0.4× 328 0.7× 426 1.0× 63 1.7k
Falk Melzer Germany 33 2.3k 1.7× 1.5k 1.3× 1.4k 2.0× 240 0.5× 240 0.6× 129 3.3k
María Laura Boschiroli France 25 923 0.7× 1.6k 1.3× 253 0.4× 1.3k 2.9× 211 0.5× 42 2.5k
C. M. Marín Spain 32 2.2k 1.7× 1.1k 0.9× 1.2k 1.7× 103 0.2× 478 1.1× 71 2.6k
Maggy Grayon France 27 2.5k 1.9× 1.6k 1.3× 1.3k 1.9× 176 0.4× 557 1.3× 48 2.9k
Betsy J. Bricker United States 23 2.1k 1.5× 1.1k 0.9× 1.3k 1.8× 66 0.1× 309 0.7× 35 2.3k
Philippe Le Flèche France 16 981 0.7× 838 0.7× 749 1.1× 220 0.5× 104 0.2× 18 1.6k
Vincent Weynants Belgium 26 555 0.4× 679 0.6× 199 0.3× 259 0.6× 345 0.8× 51 1.6k

Countries citing papers authored by Karl Walravens

Since Specialization
Citations

This map shows the geographic impact of Karl Walravens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Walravens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Walravens more than expected).

Fields of papers citing papers by Karl Walravens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Walravens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Walravens. The network helps show where Karl Walravens may publish in the future.

Co-authorship network of co-authors of Karl Walravens

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Walravens. A scholar is included among the top collaborators of Karl Walravens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Walravens. Karl Walravens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friel, Damien, Bruno Salaun, Anne Schuind, et al.. (2020). Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system. Influenza and Other Respiratory Viruses. 15(1). 110–120. 6 indexed citations
2.
Most, Robbert van der, Frédéric Clément, Julie Willekens, et al.. (2017). Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials. Clinical and Vaccine Immunology. 24(6). 15 indexed citations
4.
Gillard, Paul, Adrian Caplanusi, Markus Knuf, et al.. (2012). An assessment of prime‐boost vaccination schedules with AS03A‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Influenza and Other Respiratory Viruses. 7(1). 55–65. 28 indexed citations
5.
Yang, Pan‐Chyr, Chong‐Jen Yu, Shan‐Chwen Chang, et al.. (2012). Safety and immunogenicity of a split-virion AS03A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults. Journal of the Formosan Medical Association. 111(6). 333–339. 8 indexed citations
6.
Grégoire, Fabien, et al.. (2012). A serological and bacteriological survey of brucellosis in wild boar (Sus scrofa) in Belgium. BMC Veterinary Research. 8(1). 80–80. 38 indexed citations
7.
Vesikari, Timo, Jiřı́ Beran, Serge Durviaux, et al.. (2011). Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for influenza infection in a vaccine efficacy trial. Journal of Clinical Virology. 53(1). 22–28. 3 indexed citations
8.
Humblet, Marie‐France, Karl Walravens, María-Laura Boschiroli, et al.. (2009). Première évaluation et validation des pratiques d'intradermo-tuberculination des vétérinaires praticiens ruraux fondées sur un questionnaire d'enquête épidémiologique anonyme. Open Repository and Bibliography (University of Liège). 1 indexed citations
9.
Maquart, Marianne, Philippe Le Flèche, Geoffrey Foster, et al.. (2009). MLVA-16 typing of 295 marine mammal Brucella isolates from different animal and geographic origins identifies 7 major groups within Brucella ceti and Brucella pinnipedialis. BMC Microbiology. 9(1). 145–145. 98 indexed citations
10.
López‐Goñi, Ignacio, C. M. Marín, María Jesús de Miguel, et al.. (2008). Evaluation of a Multiplex PCR Assay (Bruce-ladder) for Molecular Typing of All Brucella Species, Including the Vaccine Strains. Journal of Clinical Microbiology. 46(10). 3484–3487. 208 indexed citations
11.
Soom, Ann Van, Hein Imberechts, Philippe Delahaut, et al.. (2007). Sanitary control in bovine embryo transfer How far should we go? A review. Veterinary Quarterly. 29(1). 2–17. 4 indexed citations
12.
13.
Leroy, Baptiste, Virginie Roupie, Valérie Rosseels, et al.. (2007). Antigen discovery: A postgenomic approach to paratuberculosis diagnosis. PROTEOMICS. 7(7). 1164–1176. 38 indexed citations
14.
Ewer, Katie, Paul Cockle, Stephen V. Gordon, et al.. (2006). Antigen Mining with Iterative Genome Screens Identifies Novel Diagnostics for the Mycobacterium tuberculosis Complex. Clinical and Vaccine Immunology. 13(1). 90–97. 19 indexed citations
15.
Godfroid, Jacques, Axel Cloeckaert, Jean‐Pierre Liautard, et al.. (2005). From the discovery of the Malta fever?s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Veterinary Research. 36(3). 313–326. 457 indexed citations
16.
Godfroid, Jacques, Claude Saegerman, Vincent Wellemans, et al.. (2002). How to substantiate eradication of bovine brucellosis when aspecific serological reactions occur in the course of brucellosis testing. Veterinary Microbiology. 90(1-4). 461–477. 117 indexed citations
17.
Köhler, Stephan, Euloge Ekaza, Jean‐Yves Paquet, et al.. (2002). Induction ofdnaKthrough Its Native Heat Shock Promoter Is Necessary for Intramacrophagic Replication ofBrucella suis. Infection and Immunity. 70(3). 1631–1634. 29 indexed citations
18.
Wellemans, Vincent, Karl Walravens, Morten Tryland, et al.. (1998). Phenotypic and molecular characterization of a Brucella strain isolated from a minke whale (Balaenoptera acutorostrata). Microbiology. 144(12). 3267–3273. 77 indexed citations
19.
Walravens, Karl, P. Coppe, A. Collard, et al.. (1996). Immunological response of mice to the bovine respiratory syncytial virus fusion glycoprotein expressed in recombinant baculovirus infected insect cells. Archives of Virology. 141(12). 2313–2326. 2 indexed citations
20.
Walravens, Karl, R. Kettmann, A. Collard, P. Coppe, & Arsène Burny. (1990). Sequence Comparison Between the Fusion Protein of Human and Bovine Espiratory Syncytial Viruses. Journal of General Virology. 71(12). 3009–3014. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026